Immuneering (IMRX) announced a clinical supply agreement with Regeneron Pharmaceuticals (REGN) for its anti-PD-1 therapy, Libtayo. The supply ...

Immuneering plans to evaluate IMM-1-104 in combination with Libtayo in patients with advanced non-small cell lung cancer in its ongoing Phase ...

This was the stock's second consecutive day of gains.

Pharma giant AstraZeneca urged Britain to improve the environment for businesses in order to drive investment, days after it ...

The UK government has announced a shift in its nuclear energy policy to approve additional nuclear power plants across ...

The Conference Forum today announced the launch of the 9th annual Patients as Partners® Europe event, taking place on May 20-21, 2025 at Royal National Hotel in London, UK. The meeting offers an ...

Britain on Thursday promised to free more sites for nuclear energy developments across England and Wales, seeking to attract private investment into Small Modular Reactors (SMRs) as part of its push ...

UK technical and strategic nuclear consultancy Equilibrion has been appointed by Northern Gas Networks (NGN) and Wales & West ...

Hello, and welcome, everyone, to the Cencora Q1 fiscal year 2025 earnings call. My name is Becky, and I'll be your operator today. (Operator Instructions) I will now hand over to your host, Head of ...

As a young girl in Kampala, Karmali Rashida would read stories about medicine and the human body. The deep curiosity about healing sparked something in her, a fascination with science that would one ...